|Page (1) of 1 - 03/13/18||email article||print page|
Rexahn Pharmaceuticals to Present at Two Upcoming Conferences(March 13, 2018)
B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS) on March 16
Oppenheimer 28th Annual Healthcare Conference on March 21
ROCKVILLE, Md., March 13, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced the Company will present at two upcoming conferences in March.
Peter D. Suzdak, chief executive officer of Rexahn will present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS) on Friday, March 16, 2018. The conference will be held March 15-17, 2018 at the Intercontinental Hotel in Hangzhou, China. CHIPS is focused on building cross-border relationships between Chinese and Western Healthcare investors and companies.
Douglas J. Swirsky, president and chief financial officer of Rexahn will present at the Oppenheimer 28th Annual Healthcare Conference on March 21, 2018 at 2:10 p.m. EDT. The conference is taking place on March 20-21, 2018 at the Westin New York Grand Central in New York City.